In nasopharyngeal carcinoma, EMP2 expression is generally weak or absent in tumor tissues but moderate to strong in adjacent non-tumor tissues, with higher levels of EMP2 associated with significantly longer survival times. Here, EMP2 is linked to nasopharyngeal carcinoma.